June 2024 - Qalsody (Tofersen) Approved For Use in Europe

Center for Neurologic Study
Jun 6, 2024
1 min read

Updated: Jul 9, 2024

Qualsody/Toferson conceived by CNS Director Dr. Smith and developed in collaboration with Don Cleveland (UCSD), Tim Miller (WashU), and Frank Bennett (Ionis Pharmaceuticals), has been approved by the European Union for the treatment of a familial form of Amyotrophic lateral sclerosis (ALS). Read more here.

Recent Posts

See All

Dr. Smith to Speak at the International ALS MND Meeting, December 6-8, 2024

The title of his talk is " Seed-Amplification Assays: Windows into ALS and Kindred Diseases".

April 16th, 2024 - "Chinese Translation and Validation of the Center for Neurologic Study Lability Scale" Published

The open access version of "Chinese Translation and Validation of the Center for Neurologic Study Lability Scale" has been published in...

March 2024 - Citation

Nature Neurology Reviews has highlighted a publication authored by Dr. Smith and colleagues regarding the identification of sporadic ALS...

Comments

< Back